A comparison of the effect of bcr/abl breakpoint specific phosphothiorate oligodeoxynucleotides on colony formation by bcr/abl positive and negative, CD34 enriched mononuclear cell populations

Leukemia Research

Volumn 20, Issue 5, 1996, Pages 391-395

  Chasty, Richard C ^a,b   Whetton, Anthony ^a   Lucas, Guy ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b DERRIFORD HOSPITAL   (United Kingdom)

Author keywords

Antisense oligodeoxynucleotide; bcr abl; CD34; CML; Colony inhibition

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CD34 ANTIGEN; MESSENGER RNA; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE;

ARTICLE; CHRONIC MYELOID LEUKEMIA; COLONY FORMATION; COMPARATIVE STUDY; CONTROLLED STUDY; DNA SEQUENCE; DNA STRAND BREAKAGE; HUMAN; HUMAN CELL; MONONUCLEAR CELL; ONCOGENE; PRIORITY JOURNAL; STEM CELL;

ANTIGENS, CD34; BASE SEQUENCE; BONE MARROW; BONE MARROW CELLS; FUSION PROTEINS, BCR-ABL; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOID, CHRONIC-PHASE; LEUKOCYTES, MONONUCLEAR; MOLECULAR SEQUENCE DATA; MYELOPROLIFERATIVE DISORDERS; OLIGONUCLEOTIDES; OLIGONUCLEOTIDES, ANTISENSE; REFERENCE VALUES; THIONUCLEOTIDES;

EID: 0029992277     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/0145-2126(95)00124-7     Document Type: Article

References (11)

1. Szczylik C., Skorski T., Nicolaides N. C., Manzella L., Malaguarnera L., Venturelli D., Gewitz A. M. & Calabretta B. (1991) Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxynucleotides. Science 253, 562.
2. Skorski T., Szczylik C., Malaguarnera L. & Calabretta B. (1991) Gene-targeted specific inhibition of chronic myeloid leukaemia cell growth by BCR-ABL antisense oligodeoxynucleotides. Folia Hist. et Cytobiol. 29, 85.
3. Mahon F. X., Belloc F. & Reiffers J. (1993) Antisense oligomers in chronic myeloid leukaemia. (Letter). Lancet 341, 566.
4. Skorski T., Nieborowska Skorska M., Barletta C., Malaguarnera L., Szczylik C., Chen S. T., Lange B. & Clabretta B. (1993) Highly efficient elimination of Philadelphia leukaemic cells by exposure to bcr/abl antisense oligodeoxynucleotides combined with mafosfamide. J. Clin. Invest. 92, 194.
5. De Fabritiis P., Amadori S., Calabretta B., & Mandelli F. (1993) Elimination of clonogenic Philadelphia-positive cells using BCR ABL antisense oligodeoxynucleotides. Bone Marrow Transplantation 12, 261.
6. Smetsers T. F. C. M., Skorski T., Van de Locht L. T. F., Wessels H. M. C., Pennings A. H. M., De Witte T., Calabretta B. & Mensink E. J. B. M. (1994) Antisense BCR-ABL oligonucleotides induce apoptosis in the Philadelphia chromosome positive cell line BV173. Leukaemia 8, 129.
7. Kirkland M. A., O'Brien S. G., McDonald C., Davidson R. J., Cross N. C. & Goldman J. M. (1993) BCR-ABL antisense purging in chronic myeloid leukaemia. (Letter). Lancet 342, 614.
8. Morgan G. J., Hernandez A., Chan L. C., Hughes T., Martiat P. & Wiedemann L. M. (1990) The role of alternative splicing patterns of BCR/ABL transcripts in the generation of the blast crisis of chronic myeloid leukaemia. Br. J. Haem. 76, 33.
9. Giles R. V. & Tidd D. M. (1992) Increased specificity for antisense oligodeoxynucleotide targeting of RNA cleavage by RNase H using chimeric methylphosphonodiester/ phosphodiester structures. Nucleic Acids Res. 20 (4), 763.
10. Stein C. A. & Cheng Y. C. (1993) Antisense oligonucleotides: is the bullet really magical? Science 261, 1004.
11. Segal G. M. & Smith T. D. (1993) Phosphothiorate oligodeoxynucleotides enhance IL-1 induced IL-6 production, implications for HIV treatment. Blood 82(10) , Suppl 1, (Abstract 2488).